| human | Q5 |
| P9843 | IRIS UNINA author ID | 17426 |
| P496 | ORCID iD | 0000-0001-7732-0887 |
| P3829 | Publons author ID | 2238933 |
| P1053 | ResearcherID | K-6845-2016 |
| P108 | employer | Karolinska Institutet | Q219564 |
| P734 | family name | Savarese | Q21496427 |
| Savarese | Q21496427 | ||
| Savarese | Q21496427 | ||
| P735 | given name | Gianluigi | Q21069180 |
| Gianluigi | Q21069180 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q46795772 | A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure |
| Q39765726 | ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis. |
| Q92488707 | Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaborat |
| Q113871843 | Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry |
| Q37932200 | Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. |
| Q57618824 | Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease |
| Q38113650 | Cardiac magnetic resonance for the assessment of myocardial viability: from pathophysiology to clinical practice |
| Q57618794 | Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in diabetic patients: A meta-analysis |
| Q45012331 | Changes in serum uric acid levels and cardiovascular events: a meta-analysis |
| Q38203634 | Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis. |
| Q40654313 | Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction. |
| Q47313712 | Comparison of linear versus cubic assessment of left atrial size in the prediction of atrial fibrillation development in hypertrophic cardiomyopathy. |
| Q38004404 | Coronary computed tomography: current role and future perspectives for cardiovascular risk stratification. |
| Q57618798 | Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in mice |
| Q57618842 | Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension? |
| Q40661827 | Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis |
| Q57618829 | Effects of atorvastatin and rosuvastatin on renal function: A meta-analysis |
| Q38142381 | Effects of ranolazine in symptomatic patients with stable coronary artery disease. A systematic review and meta-analysis. |
| Q51357838 | Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease. |
| Q98294319 | Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real world data from the Swedish Heart Failure Registry |
| Q46868025 | Enhanced age-dependent cerebrovascular dysfunction is mediated by adaptor protein p66Shc. |
| Q57618833 | Haemodynamics, exercise capacity and clinical events in pulmonary arterial hypertension |
| Q37022630 | Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study |
| Q57618847 | Implantable cardioverter defibrillator to prevent sudden cardiac death in a patient with systemic sclerosis: A clinical case |
| Q51305198 | Insulin resistance is associated with impaired cardiac sympathetic innervation in patients with heart failure. |
| Q96123795 | Inter-twinned relationship between heart failure and atrial fibrillation |
| Q43773726 | Left ventricular hypertrophy reduction and clinical events. A meta-regression analysis of 14 studies in 12,809 hypertensive patients |
| Q98244764 | Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure |
| Q30381121 | Molecular mechanism of endothelial and vascular aging: implications for cardiovascular disease. |
| Q57618849 | Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensive patients: a meta-analysis |
| Q49153716 | N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction |
| Q34614873 | Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials |
| Q38252605 | Nuclear assessment of right ventricle. |
| Q28484769 | Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis |
| Q46738622 | Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke |
| Q57618838 | Prevalence and severity of asymptomatic coronary and carotid artery disease in patients with lower limbs arterial disease |
| Q30873799 | Prognostic impact of metabolic syndrome in patients with chronic heart failure: data from GISSI-HF trial |
| Q57618851 | Prognostic role of myocardial single photon emission computed tomography in the elderly |
| Q38263765 | Prognostic role of transthoracic echocardiography in patients affected by heart failure and reduced ejection fraction |
| Q38286822 | Reduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials. |
| Q57618817 | Reduction of albumin urinary excretion is associated with reduced cardiovascular events in hypertensive and/or diabetic patients. A meta-regression analysis of 32 randomized trials |
| Q57618821 | Reply |
| Q57618792 | Reply to: Ezetimibe: A real effect? |
| Q38572465 | Safety and efficacy of ezetimibe: A meta-analysis. |
| Q38096637 | Takotsubo cardiomyopathy: overview. |
| Q36958768 | The Impact of Social and Cultural Engagement and Dieting on Well-Being and Resilience in a Group of Residents in the Metropolitan Area of Naples. |
| Q28085668 | The role of metabolic syndrome in heart failure |
| Q57618808 | Vitamin D and parathyroid hormone |
| Q53175737 | [Clinical applications of MIBG SPECT in chronic heart failure]. |
| Q83418005 | [Viability and left ventricular dysfunction: what changes after STICH?] |
Search more.